Page last updated: 2024-11-05

tolbutamide and Parapsoriasis

tolbutamide has been researched along with Parapsoriasis in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Parapsoriasis: The term applied to a group of relatively uncommon inflammatory, maculopapular, scaly eruptions of unknown etiology and resistant to conventional treatment. Eruptions are both psoriatic and lichenoid in appearance, but the diseases are distinct from psoriasis, lichen planus, or other recognized dermatoses. Proposed nomenclature divides parapsoriasis into two distinct subgroups, PITYRIASIS LICHENOIDES and parapsoriasis en plaques (small- and large-plaque parapsoriasis).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ELMOFTY, AM1

Other Studies

1 other study available for tolbutamide and Parapsoriasis

ArticleYear
CLINICAL OBSERVATIONS ON THE USE OF SULFONYLUREAS IN THE TREATMENT OF PSORIASIS AND SOME OTHER DERMATOSES.
    The Journal of the Egyptian Medical Association, 1963, Volume: 46

    Topics: Acne Vulgaris; Blood Glucose; Chlorpropamide; Dermatitis, Seborrheic; Diabetes Mellitus; Drug Therap

1963